Analysis of the efficacy and prognostic factors of PD-1 inhibitors in advanced gallbladder cancer

BACKGROUND: Gallbladder cancer (GBC) is highly malignant, its early diagnosis is difficult, and the 5-year survival rate is less than 5%. For patients with advanced GBC (GBCa), combined chemotherapy, radiotherapy, targeted therapy, and immunotherapy are needed to improve the overall survival (OS) ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Qitong, Wu, Chen, Ye, Huangshu, Xu, Zhenggang, Ji, Yang, Rao, Jianhua, Lu, Ling, Zhu, Yaqing, Cheng, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576663/
https://www.ncbi.nlm.nih.gov/pubmed/34790774
http://dx.doi.org/10.21037/atm-21-4747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576663/
https://www.ncbi.nlm.nih.gov/pubmed/34790774
http://dx.doi.org/10.21037/atm-21-4747

Ejemplares similares